Fatty acids stimulate AMP-activated protein kinase and enhance fatty acid oxidation in L6 myotubes

Journal of Physiology

Volumn 574, Issue 1, 2006, Pages 139-147

  Watt, Matthew J ^a,b   Steinberg, Gregory R ^b   Chen, Zhi Ping ^b   Kemp, Bruce E ^b,c   Febbraio, Mark A ^a  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOSINE PHOSPHATE; ADENYLATE KINASE; FATTY ACID DERIVATIVE; GLYCOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LINOLEIC ACID; PALMITIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; SERINE; SYNTHETIC PEPTIDE; THREONINE; PROTEIN KINASE LKB1;

ADENOVIRUS; ALLOSTERISM; ANIMAL CELL; ARTICLE; CATALYSIS; CELL ENERGY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; FATTY ACID OXIDATION; GLYCOGEN ANALYSIS; INFECTION; INHIBITION KINETICS; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; CELL LINE; ENZYME PHOSPHORYLATION; L6 CELL; MUSCLE METABOLISM; PROTEIN PROTEIN INTERACTION;

ANIMALS; CELL LINE; ENZYME ACTIVATION; FATTY ACIDS; MUSCLE FIBERS; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RATS;

EID: 33745214270     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.107318     Document Type: Article

References (38)

1. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA & Wakil SJ (2001). Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291, 2613-2616.
2. Bergmeyer HU (1974). Methods in Enzymatic Analysis. Academic Press, New York.
3. Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL & Summers SA (2003). A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278, 10297-10303.
4. Chen MB, McAinch AJ, Macaulay SL, Castelli LA, O'Brien PE, Dixon JB, Cameron-Smith D, Kemp BE & Steinberg GR (2005). Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 90, 3665-3672.
5. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR & Kemp BE (1999). AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443, 285-289.
6. Clark H, Carling D & Saggerson D (2004). Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids. Eur J Biochem 271, 2215-2224.
7. Dudley GA, Tullson PC & Terjung RL (1987). Influence of mitochondrial content on the sensitivity of respiratory control. J Biol Chem 262, 9109-9114.
8. Dyck DJ, Peters SJ, Glatz J, Gorski J, Keizer H, Kiens B, Liu S, Richter EA, Spriet LL, van der Vusse GJ & Bonen A (1997). Functional differences in lipid metabolism in resting skeletal muscle of various fiber types. Am J Physiol 272, E340-E351.
9. Fryer LG, Parbu-Patel A & Carling D (2002). The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signalling pathways. J Biol Chem 277, 25226-25232.
10. Garton AJ, Campbell DG, Carling D, Hardie DG, Colbran RJ & Yeaman SJ (1989). Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism. Eur J Biochem 179, 249-254.
11. Glass DB, Masaracchia RA, Feramisco JR & Kemp BE (1978). Isolation of phosphorylated peptides and proteins on ion exchange papers. Anal Biochem 87, 566-575.
12. Hamilton SR, O'Donnell JB Jr, Hammet A, Stapleton D, Habinowski SA, Means AR, Kemp BE & Witters LA (2002). AMP-activated protein kinase kinase: Detection with recombinant AMPK α1 subunit. Biochem Biophys Res Commun 293, 892-898.
13. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR & Hardie DG (2003). Complexes between the LKB1 tumor suppressor, STRAD α/β and MO25 α/β are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2, 28.
14. Hawley SA, Gadalla AE, Olsen GS & Hardie DG (2002). The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51, 2420-2425.
15. Hickson-Bick DL, Buja ML & McMillin JB (2000). Palmitate-mediated alterations in the fatty acid metabolism of rat neonatal cardiac myocytes. J Mol Cell Cardiol 32, 511-519.
16. Hudson ER, Pan DA, James J, Lucocq JM, Hawley SA, Green KA, Baba O, Terashima T & Hardie DG (2003). A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr Biol 13, 861-866.
17. Kemp BE, Stapleton D, Campbell DJ, Chen ZP, Murthy S, Walter M, Gupta A, Adams JJ, Katsis F, van Denderen B, Jennings IG, Iseli T, Michell BJ & Witters LA (2003). AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans 31, 162-168.
18. 2+ stimulation by unsaturated fatty acids. FEBS Lett 437, 229-232.
19. Lessard SJ, Lo Giudice SL, Lau W, Reid JJ, Turner N, Febbraio MA, Hawley JA & Watt MJ (2005). Rosiglitazone enhances glucose tolerance by mechanisms other than reduction of fatty acid accumulation within skeletal muscle. Endocrinology 145, 5665-5670.
20. Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, Boudeau J, Hawley SA, Udd L, Makela TP, Hardie DG & Alessi DR (2004). LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/ PAR-1. EMBO J 23, 833-843.
21. Merrill GF, Kurth EJ, Hardie DG & Winder WW (1997). AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273, E1107-E1112.
22. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D & Kahn BB (2002). Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343.
23. Muoio DM, Seefeld K, Witters LA & Coleman RA (1999). AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: Evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338, 783-791.
24. Passoneau JA & Lowry OH (1993). Enzymatic Analysis. Humana, Totawa, NJ, USA.
25. Polekhina G, Gupta A, Michell BJ, van Denderen B, Murthy S, Feil SC, Jennings IG, Campbell DJ, Witters LA, Parker MW, Kemp BE & Stapleton D (2003). AMPK β subunit targets metabolic stress sensing to glycogen. Curr Biol 13, 867-871.
26. Randle PJ, Garland PB, Hales CN & Newsholme EA (1963). The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785-789.
27. Sakamoto K, McCarthy A, Smith D, Green KA, Hardie GD, Ashworth A & Alessi DR (2005). Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 24, 1810-1820.
28. Sambandam N, Steinmetz M, Chu A, Altarejos JY, Dyck JR & Lopaschuk GD (2004). Malonyl-CoA decarboxylase (MCD) is differentially regulated in subcellular compartments by 5′AMP-activated protein kinase (AMPK). Studies using H9c2 cells overexpressing MCD and AMPK by adenoviral gene transfer technique. Eur J Biochem 271, 2831-2840.
29. Shulman GI (2000). Cellular mechanisms of insulin resistance. J Clin Invest 106, 171-176.
30. Suchankova G, Tekle M, Saha AK, Ruderman NB, Clarke SD & Gettys TW (2005). Dietary polyunsaturated fatty acids enhance hepatic AMP-activated protein kinase activity in rats. Biochem Biophys Res Commun 326, 851-858.
31. Tagliaferro AR, Dobbin S, Curi R, Leighton B, Meeker LD & Newsholme EA (1990). Effects of diet and exercise on the in vivo rates of the triglyceride-fatty acid cycle in adipose tissue and muscle of the rat. Int J Obes 14, 957-971.
32. Taylor EB, Ellingson WJ, Lamb JD, Chesser DG & Winder WW (2005). Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25. Am J Physiol Endocrinol Metab 288, E1055-E1061.
33. van Hall G, Sacchetti M, Radegran G & Saltin B (2002). Human skeletal muscle fatty acid and glycerol metabolism during rest, exercise and recovery. J Physiol 543, 1047-1058.
34. Watt MJ, Holmes AG, Pinnamaneni SK, Garnham AP, Steinberg GR, Kemp BE & Febbraio MA (2005). Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab 290, E500-E508.
35. Watt MJ, Steinberg GR, Chan S, Garnham A, Kemp BE & Febbraio MA (2004). β-adrenergic stimulation of skeletal muscle HSL can be overridden by AMPK signalling. FASEB J 18, 1445-1446.
36. Wojtaszewski JF, MacDonald C, Nielsen JN, Hellsten Y, Hardie DG, Kemp BE, Kiens B & Richter EA (2003). Regulation of 5′AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab 284, E813-E822.
37. Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferre P, Foufelle F & Carling D (2000). Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20, 6704-6711.
38. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M & Carling D (2003). LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13, 2004-2008.